Sven Enterlein

1.8k total citations
17 papers, 1.0k citations indexed

About

Sven Enterlein is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Sven Enterlein has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 5 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Sven Enterlein's work include Viral Infections and Outbreaks Research (12 papers), Viral Infections and Vectors (10 papers) and Viral gastroenteritis research and epidemiology (8 papers). Sven Enterlein is often cited by papers focused on Viral Infections and Outbreaks Research (12 papers), Viral Infections and Vectors (10 papers) and Viral gastroenteritis research and epidemiology (8 papers). Sven Enterlein collaborates with scholars based in United States, Germany and France. Sven Enterlein's co-authors include Elke Mühlberger, Ramon Flick, Kelly L. Warfield, M. Javad Aman, Mike C. Wolf, Oscar Negrete, Stephen Su, Andrea Bertolotti‐Ciarlet, Wei Wang and Benhur Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Sven Enterlein

17 papers receiving 969 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sven Enterlein United States 15 726 483 156 103 69 17 1.0k
Kathryn M. Hastie United States 19 863 1.2× 294 0.6× 246 1.6× 92 0.9× 124 1.8× 37 1.1k
Jillian M. Licata United States 8 437 0.6× 290 0.6× 70 0.4× 83 0.8× 78 1.1× 9 627
Masaharu Iwasaki Japan 14 481 0.7× 391 0.8× 101 0.6× 55 0.5× 115 1.7× 29 727
Lesley C. Dupuy United States 17 471 0.6× 304 0.6× 244 1.6× 216 2.1× 109 1.6× 29 819
Sébastien Emonet France 16 819 1.1× 224 0.5× 76 0.5× 183 1.8× 97 1.4× 24 1.0k
Mary C. Guttieri United States 11 634 0.9× 191 0.4× 95 0.6× 98 1.0× 67 1.0× 15 735
Tatyana Yun United States 10 355 0.5× 397 0.8× 102 0.7× 117 1.1× 84 1.2× 14 641
Elisabetta Groppelli United Kingdom 14 282 0.4× 100 0.2× 191 1.2× 57 0.6× 55 0.8× 24 628
Catherine L. Hunt United States 8 541 0.7× 207 0.4× 113 0.7× 121 1.2× 79 1.1× 8 749
Sandra Scianimanico France 8 326 0.4× 333 0.7× 155 1.0× 181 1.8× 88 1.3× 8 718

Countries citing papers authored by Sven Enterlein

Since Specialization
Citations

This map shows the geographic impact of Sven Enterlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Enterlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Enterlein more than expected).

Fields of papers citing papers by Sven Enterlein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Enterlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Enterlein. The network helps show where Sven Enterlein may publish in the future.

Co-authorship network of co-authors of Sven Enterlein

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Enterlein. A scholar is included among the top collaborators of Sven Enterlein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Enterlein. Sven Enterlein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zeitlin, Larry, Robert W. Cross, Joan B. Geisbert, et al.. (2021). Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody. Proceedings of the National Academy of Sciences. 118(11). 14 indexed citations
2.
Adhikari, Rajan P., Christian Haudenschild, Patricia M. Sterba, et al.. (2016). Development of a novel multiplex electrochemiluminescent-based immunoassay for quantification of human serum IgG against 10 Staphylococcus aureus toxins. Journal of Immunological Methods. 430. 33–42. 6 indexed citations
3.
Warfield, Kelly L., Dale L. Barnard, Sven Enterlein, et al.. (2016). The Iminosugar UV-4 is a Broad Inhibitor of Influenza A and B Viruses ex Vivo and in Mice. Viruses. 8(3). 71–71. 34 indexed citations
4.
Warfield, Kelly L., Emily M. Plummer, Dominic S. Alonzi, et al.. (2015). A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue). Viruses. 7(5). 2404–2427. 26 indexed citations
5.
Keck, Zhen–Yong, Sven Enterlein, Katie A. Howell, et al.. (2015). Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein. Journal of Virology. 90(1). 279–291. 63 indexed citations
7.
Hu, Lei, Yuhong Zeng, Luisa Yee, et al.. (2011). Biophysical Characterization and Conformational Stability of Ebola and Marburg Virus-Like Particles. Journal of Pharmaceutical Sciences. 100(12). 5156–5173. 22 indexed citations
8.
Spurgers, Kevin B., Brian D. Peyser, Gordon Ruthel, et al.. (2010). Identification of Essential Filovirion-associated Host Factors by Serial Proteomic Analysis and RNAi Screen. Molecular & Cellular Proteomics. 9(12). 2690–2703. 63 indexed citations
9.
Warren, Travis K., Kelly L. Warfield, Jay Wells, et al.. (2010). Antiviral Activity of a Small-Molecule Inhibitor of Filovirus Infection. Antimicrobial Agents and Chemotherapy. 54(5). 2152–2159. 58 indexed citations
10.
Aman, M. Javad, Michael S. Kinch, Kelly L. Warfield, et al.. (2009). Development of a broad-spectrum antiviral with activity against Ebola virus. Antiviral Research. 83(3). 245–251. 75 indexed citations
11.
Enterlein, Sven, Kristina M. Schmidt, Michael Schümann, et al.. (2009). The Marburg Virus 3′ Noncoding Region Structurally and Functionally Differs from That of Ebola Virus. Journal of Virology. 83(9). 4508–4519. 23 indexed citations
13.
Negrete, Oscar, Mike C. Wolf, Hector C. Aguilar, et al.. (2006). Two Key Residues in EphrinB3 Are Critical for Its Use as an Alternative Receptor for Nipah Virus. PLoS Pathogens. 2(2). e7–e7. 244 indexed citations
14.
Enterlein, Sven, Kelly L. Warfield, Dana L. Swenson, et al.. (2006). VP35 Knockdown Inhibits Ebola Virus Amplification and Protects against Lethal Infection in Mice. Antimicrobial Agents and Chemotherapy. 50(3). 984–993. 97 indexed citations
15.
Enterlein, Sven, Viktor E. Volchkov, Larissa Kolesnikova, et al.. (2005). Rescue of Recombinant Marburg Virus from cDNA Is Dependent on Nucleocapsid Protein VP30. Journal of Virology. 80(2). 1038–1043. 66 indexed citations
16.
Enterlein, Sven, et al.. (2005). The Ebola Virus Genomic Replication Promoter Is Bipartite and Follows the Rule of Six. Journal of Virology. 79(16). 10660–10671. 54 indexed citations
17.
Enterlein, Sven, et al.. (2004). A reconstituted replication and transcription system for Ebola virus Reston and comparison with Ebola virus Zaire. Virology. 332(1). 406–417. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026